Lloyd Czaplewski is an entrepreneurial scientist with over 35 years of R&D experience in biological and chemical entities. As Chief Scientific Officer at Persica Pharmaceuticals and Director at Chemical Biology Ventures, he focuses on antibacterial research and novel therapies. He is a Fellow of the Royal Society of Chemistry and holds a degree from the University of East Anglia.
Lloyd has a deep interest in the translation of research into tangible therapies, a passion that has driven his career in the biotech industry. He enjoys working with diverse teams on projects that span from concept to clinical evaluation, viewing such opportunities as career highlights, particularly in developing treatments for debilitating conditions.
He won the Elsevier Atlas Award in March 2016 for his influential review on "Alternatives to Antibiotics, " recognizing its potential global impact.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.